Orchard Cash Pile Set To Rise With Nasdaq IPO
The UK gene therapy firm was only set up in 2016 but after raising $260m in two financing rounds since the end of 2017, Orchard has filed documents with a view to listing on NASDAQ.
The UK gene therapy firm was only set up in 2016 but after raising $260m in two financing rounds since the end of 2017, Orchard has filed documents with a view to listing on NASDAQ.